SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Vertex Pharmaceuticals (VRTX)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1169 64 0 VRTX
Emcee:  David Lieberman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
419 << mention JNK3 (c-jun-N-terminal kinase 3) >> Correct as usual. tommysdad-5/16/2000
418 go to another thread? yeah, sounds good. however, before we depart.... yup,scaram(o)uche-5/16/2000
417 Thanks for your insights, as usual. BioCentury's story on the deal does mePseudo Biologist-5/16/2000
416 Thanks. Guess I should have known that. Let's hope NVSTY has done better tommysdad-5/16/2000
415 td, Not impugning the Novartis deal, VRTX is great science. Ciba bought 49% obiowa-5/16/2000
414 competitive project, one of about 10E6 for inflammation, just FI..... Tuesday scaram(o)uche-5/16/2000
413 Simply put, this is a great deal for VRTX. I guess the market was anticipatingBiotech Jim-5/13/2000
412 <<Ciba (now, Novartis) and CHIR, November, 1994? >> Thanks. A littommysdad-5/13/2000
411 tommysdad, <i>this is Novartis trusting Vertex to make the right decisiobiowa-5/12/2000
410 >> It sounds too good to be true. Is it? << Don't think so. Gscaram(o)uche-5/11/2000
409 Wow. One of the most visionary alliances in recent biotech history and no reactommysdad-5/11/2000
408 Tuesday May 9, 5:59 am Eastern Time Company Press Release SOURCE: Vertex Pharscaram(o)uche-5/9/2000
407 [ peripheral interest, perhaps ] Tuesday March 28, 7:00 am Eastern Time Compascaram(o)uche-3/28/2000
406 Just parking. Go Aventis. IL-1 Blockade Inhibits Murine Arthritis -----------Miljenko Zuanic-3/23/2000
405 Refractory ovarian/breast cancer seams to be *reasonable* target for INCEL/TaxoMiljenko Zuanic-3/7/2000
404 Richard IMO, treating ovarian patients that fail taxol and the pt drugs is verseminole-3/7/2000
403 today from XNVA, no comments on efficacy.... biz.yahoo.com "The Phase IIscaram(o)uche-3/7/2000
402pnas.org Immunology IL-18 binding protein increases spontaneous and IL-1-induceMiljenko Zuanic-3/2/2000
401 <<Please J.B., borrow Levin's vision on few minutes. It shouldn'tMiljenko Zuanic-2/29/2000
400 >> Time to hit the capital markets? << Let's hope so..... 75 scaram(o)uche-2/29/2000
399 Time to hit the capital markets? This was telegraphed during last weeks quarrkrw-2/29/2000
398 From BW: <<Turning Data into Drugs--Fast This summer, scientists expectMiljenko Zuanic-2/26/2000
397 Vertex Pharmaceuticals will be on Informed Investors Radio at 11am EST. Audio sean_finn-2/23/2000
396 Anyone out there still interested in fundamental bio-technology valuation? Or, Miljenko Zuanic-2/22/2000
395 Thanks VRTX for CC reply on web!Miljenko Zuanic-2/16/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News